Philadelphia Mesothelioma Attorneys Report on New Orphan Drug
August 3, 2012 – Bayer Healthcare, a ground-breaking, global leader in the medical treatments industry, is committed to improving the prognosis of mesothelioma patients, as well as improving their quality of life. The company has announced that its researchers have obtained “orphan drug” status for a new treatment for mesothelioma patients. The investigational anti-cancer agent, […]